Journal article
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy
The Journal of nuclear medicine (1978), Vol.61(2), pp.222-227
02/01/2020
DOI: 10.2967/jnumed.119.240911
PMCID: PMC9364765
PMID: 32015164
Abstract
no abstract
Details
- Title: Subtitle
- NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy
- Creators
- Thomas A. Hope - University of California, San FranciscoLisa Bodei - Memorial Sloan Kettering Cancer CenterJennifer A. Chan - Dana-Farber Cancer InstituteGhassan El-Haddad - Moffitt Cancer CenterNicholas Fidelman - University of California, San FranciscoPamela L. Kunz - Stanford UniversityJosh Mailman - NorCal CarciNET Community, Ripon, California.Yusuf Menda - Roy J. and Lucille A. Carver College of MedicineDavid C. Metz - University of PennsylvaniaErik S. Mittra - Oregon Health & Science UniversityDaniel A. Pryma - University of PennsylvaniaDiane L. Reidy-Lagunes - Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USASimron Singh - Sunnybrook Health Science CentreJonathan R. Strosberg - Moffitt Cancer Center
- Resource Type
- Journal article
- Publication Details
- The Journal of nuclear medicine (1978), Vol.61(2), pp.222-227
- DOI
- 10.2967/jnumed.119.240911
- PMID
- 32015164
- PMCID
- PMC9364765
- NLM abbreviation
- J Nucl Med
- ISSN
- 0161-5505
- eISSN
- 1535-5667
- Publisher
- Soc Nuclear Medicine Inc
- Number of pages
- 6
- Language
- English
- Date published
- 02/01/2020
- Academic Unit
- Radiology; Radiation Oncology
- Record Identifier
- 9984312972302771
Metrics
16 Record Views